ImmunoPET: Bridging Molecular Imaging and Targeted Therapy

Auditori Plaza HSJD

15h

IRSJD November Scientific Seminar: "ImmunoPET: Bridging Molecular Imaging and Targeted Therapy". Raul Herance Camacho (VHIR). Host: Dr. Jame Mora.

Abstract

The ability to visualise, characterise and monitor immune responses in vivo is becoming increasingly important for the development of precision medicine and innovative therapeutic strategies. ImmunoPET, combining the molecular specificity of antibodies and immune-targeting molecules with the sensitivity and quantitative capabilities of positron emission tomography, offers unique opportunities to investigate immune cell populations, their functional states and their interactions with tissues in different pathological conditions. Importantly, ImmunoPET can act as a non-invasive virtual biopsy, providing whole-body molecular characterisation of disease, revealing spatial heterogeneity and identifying specific therapeutic targets that may not be captured by conventional tissue sampling. This approach opens new possibilities for patient stratification, treatment selection and longitudinal monitoring of disease and therapeutic responses.

Short biography

Research Head of Imatge i Teràpia Molecular, Vall Hebron Institut de Recerca.